Extracorporeal Shock Wave Lithotripsy: Long-Term Effectiveness

Extracorporeal Shock Wave Lithotripsy: Long-Term Effectiveness Overview The study aimed to conduct a comprehensive audit spanning seven years with a three-year follow-up at a high-volume stone center that specializes in extracorporeal shock wave lithotripsy (ESWL). The primary objectives were to assess the efficacy of ESWL in stone clearance in comparison to existing

PD-1/L1 Inhibitors: Treatment Efficacy In Urothelial Carcinoma

PD-1/L1 Inhibitors: Treatment Efficacy In Urothelial Carcinoma Overview Programmed cell death‐1/ligand 1 (PD-1/PD-L1) inhibitors represent a novel therapeutic approach for advanced urothelial carcinoma, prompting the need for a comparative assessment of their effectiveness and safety in comparison to traditional chemotherapy. To address this, a comprehensive meta-analysis of randomized controlled trials conducted until

Extracorporeal Shock Wave Lithotripsy: Long-Term Effectiveness